# Micheál Martin

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/michel-martin
Canonical HTML page: https://getbiobrief.com/entity/michel-martin

## Recent coverage (1 stories)

### Skyclarys Ireland Reimbursement Rebuff Leaves 200 FA Patients in Limbo
2026-08-16 14:35:34 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

For biopharma, Ireland's HSE Drugs Group non-recommendation for Skyclarys highlights the mounting gap between EMA approval and national reimbursement in rare diseases. The decision, citing evidence limitations and price, leaves around 200 Irish patients without public access despite EU-wide authorization since February 2024.
Full story: https://getbiobrief.com/story/biotech-skyclarys-ireland-reimbursement-hta-challenge

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.